OR OR
Company Profile ↓Company Overview
OR (OR) is a publicly traded company listed on with a market capitalization of $6.03B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 20.0% CAGR over the past five years.
Maintains a net profit margin of 74.3%.
Carries low leverage with a debt-to-equity ratio of 0.35.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $277.37M (+45.1% YoY); net profit $206.09M.
- Trailing 12 Months Year-on-year growth — revenue +45.1%, earnings +1166.9%.
- 5-Year Trend Long-term compounding — revenue CAGR 20.0%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 20.01% |
| 1 Year: | 45.10% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | 1,166.91% |
Stock Price Performance
| 1 Year: | +12.04% |
| 6 Months: | -19.67% |
| 3 Months: | -10.49% |
| 1 Month: | +7.07% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)60.70 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 74.3%.
- Compounding revenue at 20.0% over 5 years.
- Generates positive free cash flow.
CONS
- Trading 32.2% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 54.92M | 60.36M | 71.62M | 90.47M | 102.83M |
| Cost of Revenue | - | 9.36M | 10.17M | 12.53M | 12.82M | 13.99M |
| Gross Profit | 44.34M | 45.55M | 50.19M | 59.10M | - | 88.84M |
| Operating Expenses | - | 7.04M | 8.76M | 6.92M | 7.51M | 8.59M |
| Operating Income | - | 38.52M | 41.43M | 52.18M | 70.14M | 80.25M |
| EBITDA | - | 43.27M | 48.48M | 103.47M | 87.64M | 99.42M |
| Interest Expense | - | 1.73M | 1.12M | 886.00K | 735.00K | 762.00K |
| Pretax Income | - | 33.51M | 39.45M | 92.09M | 76.34M | 87.66M |
| Tax Provision | - | 7.87M | 7.09M | 9.24M | 11.10M | 14.08M |
| Net Income | - | 25.64M | 32.36M | 82.84M | 65.25M | 73.58M |
| Diluted EPS | - | 0.14 | 0.17 | 0.44 | - | 0.39 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 160.48M | 183.23M | 191.16M | 277.37M |
| Cost of Revenue | - | 49.68M | 54.14M | 39.34M | 44.88M |
| Gross Profit | - | 110.80M | 129.09M | 151.81M | 232.49M |
| Operating Expenses | - | 18.86M | 56.75M | 22.53M | 30.23M |
| Operating Income | - | 91.94M | 72.34M | 129.28M | 202.26M |
| EBITDA | - | 138.43M | 29.10M | 71.68M | 282.85M |
| Interest Expense | - | 16.46M | 14.03M | 7.97M | 4.47M |
| Pretax Income | - | 83.35M | -27.64M | 30.14M | 241.38M |
| Tax Provision | - | 20.51M | 9.79M | 13.88M | 35.30M |
| Net Income | - | -87.50M | -37.43M | 16.27M | 206.09M |
| Diluted EPS | - | -0.49 | -0.20 | 0.09 | 1.09 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 1.47B | 1.49B | 1.38B | 1.57B |
| Current Assets | - | 77.37M | 63.55M | 63.81M | 147.68M |
| Cash & Equivalents | - | 66.85M | 51.20M | 59.10M | 142.13M |
| Inventory | 14.58M | 9.58K | 10.00K | 0 | - |
| Receivables | - | 8.64M | 3.10M | 2.11M | 2.28M |
| Total Liabilities | - | 191.29M | 238.54M | 188.68M | 134.44M |
| Current Liabilities | - | 13.19M | 15.46M | 14.62M | 32.63M |
| Long Term Debt | 90.62M | 109.23M | 145.08M | 93.90M | - |
| Total Debt | - | 114.86M | 151.13M | 98.68M | 5.00M |
| Total Equity | - | 1.28B | 1.25B | 1.19B | 1.43B |
| Shares Outstanding | - | 184.01M | 185.35M | 186.68M | 187.15M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 81.01M | 138.44M | 159.93M | 245.60M |
| Investing Cash Flow | - | -281.36M | -166.13M | -75.64M | 1.35M |
| Financing Cash Flow | - | 161.54M | 9.37M | -74.87M | -163.35M |
| Capital Expenditure | - | -91.52M | -217.75M | -73.45M | -36.88M |
| Free Cash Flow | - | -10.51M | -79.31M | 86.48M | 208.72M |
| Net Change in Cash | - | -38.81M | -18.32M | 9.41M | 83.60M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 69.0% | 70.5% | 79.4% | 83.8% |
| Operating Margin % | - | 57.3% | 39.5% | 67.6% | 72.9% |
| Net Margin % | - | -54.5% | -20.4% | 8.5% | 74.3% |
| ROE % | - | -6.8% | -3.0% | 1.4% | 14.4% |
| ROCE % | - | 6.3% | 4.9% | 9.5% | 13.2% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for OR
L'Oréal (ENXTPA:OR) Stock Looks About Right With Cash Flow Support And Richer Earnings - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxQYXRRcC1GbWVacWpEWnhBS0JIdWpYVE5sWWdYNm5ZenZqdnlqVkpiVTNoNzNfRGUtcGNuMWpSa2g1QUlvbDM4TENnTHdtTElGMUloUGlNOFNFWk5salhpVXZYVGp5VUNGMnkzbnhSeDVxOFYwUldhMUJqTk1Ma0tza1JaMTNlMXQ3Q3h3eW…
No deal between AstraZeneca and BMS, senior source insists: Reuters - BioSpace
<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxPVFV6UEtkbHllT3ROZFVBOFo0TkozNm93WXZoOGFEeFQxMi1odkNXV19zWlpOZ1hia1g0cS1iaTJzWG8xVW9FWlczbjRRMTZWLTNFSWoxYzdORjh2eFFZUGUzNklfOWh6UW5GUGhicVY1VV9Ob3A4Y0NLMy04YTRXVm5EakRYZmhTRFR6eH…
Sector First or Stock First? Two Workflows for Growth Investors - ChartMill
<a href="https://news.google.com/rss/articles/CBMi2gFBVV95cUxOY0xYRjBpTDlrcFdTLTJiNXU5bWtORlQwLXBuMzN6b0l1SFk4SmdUY3EzZXBxMWdQbUJuYVY0VEdNR1c4bm9VOUh3dVJhMzhSaUdHd2VLbHVDMVNfX25Gd2lXQUZSX21VRDJnNGFBQUxob2tkNlR5Z25BUXgzOVdTekRCUy1tSzgwNXdFaz…
Most Store-Bought Chicken Stock Isn’t Really Stock—Here’s How It Changes Your Cooking - Serious Eats
<a href="https://news.google.com/rss/articles/CBMie0FVX3lxTFBFMWFJMlVQY0d2azBQNmJ4aGhySmZpOVg5bXBUYXpBTUFCc0hVRFJ6TktJT05QRk9HejhZbEdIdkVpQ0lQQmRQTHFMS0pJOGZrRl9RMGIzUGd4MWVldy1MNWVsVExRZGlzQzBvOVlGVHVwWTdDMzRxYVJFYw?oc=5" target="_blank">M…
Here's our advice for investors looking to buy the dip in volatile AI stocks - CNBC
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxQc25FRWxaYnlNZlUtSVhDSFFhcHRiSGRuNFBFNEdKVkNUWHlhWkxFYXRWUHpwSDhUV2dNTmRvakFQY1g5czd3YUw1YVQ3N1BpQTJlU215UWlaOVZ4R1JIX3dncW5YSzV1ZEd1alZnRDkzTU5zZWNVajc2QnlSekcwSjZjcHVpQ3FQNmNQRm…
L'Oréal (ENXTPA:OR) Stock Premium Holds After Record Margin And Cash Flow - simplywall.st
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxOWDRpenpSWWRBc185N3YxcmpvMkV4V3RDY3ZRSDFOelI4dEk0TUVuazVhVXctdmM3ZkNtbkRfTmdqTUtWdUhQeDBhdXZITWlnYmpqUkxJWVlWN25hMU0zanlFcmREZTFiZ0ZfN25McWdVM1RIN1R2NG9uc20yY3pwS0dtY2ZLdk1SV2dtVT…
OR — Frequently Asked Questions
What is the current share price of OR?
As of 2026-08-05 17:25 PDT, OR trades at $32.24 on NASDAQ/NYSE. Its 52-week range is $28.05 to $47.56.
What is the market capitalisation of OR?
OR has a market capitalisation of $6.03B on NASDAQ/NYSE.
What is the P/E ratio of OR?
OR trades at a trailing price-to-earnings (P/E) ratio of 29.58. Its price-to-book (P/B) ratio is 4.21.
What is the return on equity (ROE) of OR?
OR has a return on equity (ROE) of 14.39%. Its return on capital employed (ROCE) is 13.19%.
Is OR a good stock to buy?
This page provides a data-driven analysis of OR, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.